Le Lézard
Classified in: Health
Subjects: HEALTH, FOOD/COOKING, MISCELLANEOUS, MISCELLANEOUS, Environmental, Social, and Governance Criteria

Holy Cow Foods To Develop State of the Art Fully Automated Green Hydrogen Powered Facilities


Vancouver, British Columbia, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Holy Cow Foods Inc. (NEO: HOLY; OTC: HCWFF; Frankfurt: Z34) ("Holy Cow" or the "Company") is pleased to announce an initiative to develop facilities incorporating automated robotic machinery powered by green hydrogen.

The initiative was designed to address various economic trends affecting the Company and its customers, including increasing food prices, labour shortages and high energy prices, while aligning with the Company's values and the environmental, social and governance (ESG) objectives of its customers. Through the initiative, the Company intends to commission vertically integrated facilities powered by green hydrogen, offering production, processing, co-packing and ghost kitchen services all under one roof.

Holy Cow's current facility is located two minutes from the Vancouver, BC, downtown core on one of the city's busiest throughfares.

About Holy Cow
Holy Cow is a multi-division food manufacturing operation that offers Ghost Kitchens, Commissary Kitchens, Co-pack Manufacturing and Private Label Manufacturing powered by clean energy.

For Further Information:
For investor inquiries or further information, please contact:
Paul Rivas, Chief Executive Officer
1 (236) 471-1357
[email protected]

Cautionary Note on Forward-Looking Information
This press release contains certain forward-looking statements within the meaning of applicable securities laws with respect to the Company. These forward-looking statements generally are identified by words such as "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," and similar expressions and in this news release include statements respecting trends affecting the Company and its customers, the Company's plan to develop new facilities with automated machinery and power same with green hydrogen and the effect of such initiatives on the Company's operations and sales. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable laws

The Neo Exchange has not reviewed or approved this press release for the adequacy or accuracy of its contents.



These press releases may also interest you

at 06:18
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...

at 05:00
WellSync, an API-driven virtual care service provider, today announced its partnership with The Vitamin Shoppe to launch Whole Health Rx, a cutting-edge telehealth service providing access to GLP-1 medications for weight management. WellSync provides...

at 04:00
May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands...



News published on and distributed by: